OTCPK:SSMX.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. More Details

Rewards

Earnings are forecast to grow 13.03% per year

Risk Analysis

No risks detected for SSMX.F from our risk checks.


Snowflake Analysis

Flawless balance sheet with questionable track record.


Similar Companies

Share Price & News

How has Sysmex's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SSMX.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

SSMX.F

0.6%

US Medical Equipment

1.3%

US Market


1 Year Return

29.5%

SSMX.F

17.1%

US Medical Equipment

15.8%

US Market

Return vs Industry: SSMX.F exceeded the US Medical Equipment industry which returned 17.1% over the past year.

Return vs Market: SSMX.F exceeded the US Market which returned 15.8% over the past year.


Shareholder returns

SSMX.FIndustryMarket
7 Day0%0.6%1.3%
30 Day7.3%-2.4%-4.1%
90 Day16.7%10.6%8.4%
1 Year29.5%29.5%18.1%17.1%18.4%15.8%
3 Year35.1%35.1%70.9%66.5%38.2%29.0%
5 Year59.4%59.4%144.0%125.3%84.9%64.0%

Price Volatility Vs. Market

How volatile is Sysmex's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Sysmex undervalued compared to its fair value and its price relative to the market?

65.63x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: SSMX.F ($86.05) is trading above our estimate of fair value ($34.29)

Significantly Below Fair Value: SSMX.F is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: SSMX.F is poor value based on its PE Ratio (65.6x) compared to the US Medical Equipment industry average (49.6x).

PE vs Market: SSMX.F is poor value based on its PE Ratio (65.6x) compared to the US market (18x).


Price to Earnings Growth Ratio

PEG Ratio: SSMX.F is poor value based on its PEG Ratio (5x)


Price to Book Ratio

PB vs Industry: SSMX.F is overvalued based on its PB Ratio (7.8x) compared to the US Medical Equipment industry average (4x).


Next Steps

Future Growth

How is Sysmex forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?

13.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SSMX.F's forecast earnings growth (13% per year) is above the savings rate (2.2%).

Earnings vs Market: SSMX.F's earnings (13% per year) are forecast to grow slower than the US market (22.8% per year).

High Growth Earnings: SSMX.F's earnings are forecast to grow, but not significantly.

Revenue vs Market: SSMX.F's revenue (8.2% per year) is forecast to grow slower than the US market (9.9% per year).

High Growth Revenue: SSMX.F's revenue (8.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SSMX.F's Return on Equity is forecast to be low in 3 years time (14.1%).


Next Steps

Past Performance

How has Sysmex performed over the past 5 years?

1.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SSMX.F has high quality earnings.

Growing Profit Margin: SSMX.F's current net profit margins (11.1%) are lower than last year (13%).


Past Earnings Growth Analysis

Earnings Trend: SSMX.F's earnings have grown by 1.7% per year over the past 5 years.

Accelerating Growth: SSMX.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SSMX.F had negative earnings growth (-15.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (1.8%).


Return on Equity

High ROE: SSMX.F's Return on Equity (11.8%) is considered low.


Next Steps

Financial Health

How is Sysmex's financial position?


Financial Position Analysis

Short Term Liabilities: SSMX.F's short term assets (¥185.6B) exceed its short term liabilities (¥66.5B).

Long Term Liabilities: SSMX.F's short term assets (¥185.6B) exceed its long term liabilities (¥26.0B).


Debt to Equity History and Analysis

Debt Level: SSMX.F is debt free.

Reducing Debt: SSMX.F had no debt 5 years ago.

Debt Coverage: SSMX.F has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: SSMX.F has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Sysmex current dividend yield, its reliability and sustainability?

0.70%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: SSMX.F's dividend (0.7%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.71%).

High Dividend: SSMX.F's dividend (0.7%) is low compared to the top 25% of dividend payers in the US market (4.83%).


Stability and Growth of Payments

Stable Dividend: SSMX.F is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: SSMX.F is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: SSMX.F is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SSMX.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.4yrs

Average management tenure


CEO

Hisashi Ietsugu (71 yo)

24.25yrs

Tenure

JP¥195,000,000

Compensation

Mr. Hisashi Ietsugu has been the Chairman of the Managing Board at Sysmex Corporation (a holding company of Sysmex America Inc.) at Sysmex India Pvt. Ltd. since April 2013 and its Chief Executive Officer s ...


CEO Compensation Analysis

Compensation vs Market: Hisashi's total compensation ($USD1.85M) is below average for companies of similar size in the US market ($USD11.35M).

Compensation vs Earnings: Hisashi's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Hisashi Ietsugu
Chairman of the Managing Board & CEO24.25yrsJP¥195.00m0.29%
¥ 59.4m
Yukio Nakajima
Senior Exec. Officer21.25yrsno data0.045%
¥ 9.2m
Kaoru Asano
CTO, COO LS Business Unit6.25yrsno data0.026%
¥ 5.3m
Tomoo Aramaki
Executive Vice President of Corporate Business Administrationno datano datano data
Yukio Hamaguchi
Senior Executive Officer & Executive VP of Reagent Production1.67yrsno datano data
Junzo Yamamoto
Senior Executive Officer3.25yrsno data0.014%
¥ 2.8m
Iwane Matsui
Senior Executive Officer1.25yrsno data0.00048%
¥ 97.5k
Kenji Tachibana
Senior Executive Officer6.25yrsno data0.015%
¥ 3.0m
Ikuo Otani
Senior Executive Officer1.67yrsno datano data
Hiroshi Kanda
Senior Executive Officer1.25yrsno data0.026%
¥ 5.3m
Mamoru Kubota
Senior Executive Officerno datano datano data
Kensuke Lizuka
Senior Executive Officerno datano datano data

3.4yrs

Average Tenure

63yo

Average Age

Experienced Management: SSMX.F's management team is considered experienced (3.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Hisashi Ietsugu
Chairman of the Managing Board & CEO24.25yrsJP¥195.00m0.29%
¥ 59.4m
Yukio Nakajima
Senior Exec. Officer21.25yrsno data0.045%
¥ 9.2m
Kaoru Asano
CTO, COO LS Business Unit6.25yrsno data0.026%
¥ 5.3m
Junzo Yamamoto
Senior Executive Officer3.25yrsno data0.014%
¥ 2.8m
Iwane Matsui
Senior Executive Officer1.25yrsno data0.00048%
¥ 97.5k
Kenji Tachibana
Senior Executive Officer6.25yrsno data0.015%
¥ 3.0m
Hiroshi Kanda
Senior Executive Officer1.25yrsno data0.026%
¥ 5.3m
Yukitoshi Kamao
Member of the Managing Board4.25yrsno data0.022%
¥ 4.5m
Kazuo Ota
Independent Outside Member of the Managing Board1.25yrsno datano data
Masayo Takahashi
Independent Outside Member of the Managing Board4.25yrsno datano data
Kazumasa Hashimoto
Independent Outside Member of the Managing Board0.67yrno datano data
Michihide Iwasa
Independent Outside Member of Managing Board0.67yrno datano data

3.8yrs

Average Tenure

63.5yo

Average Age

Experienced Board: SSMX.F's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sysmex Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sysmex Corporation
  • Ticker: SSMX.F
  • Exchange: OTCPK
  • Founded: 1968
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: JP¥2.145t
  • Listing Market Cap: JP¥20.315b
  • Shares outstanding: 208.89m
  • Website: https://www.sysmex.co.jp

Number of Employees


Location

  • Sysmex Corporation
  • 1-5-1, Wakinohama-Kaigandori
  • Chuo-ku
  • Kobe
  • Hyogo
  • 651-0073
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SSMX.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDNov 1995
6869TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYNov 1995
0YXDB (Deutsche Boerse AG)YesCommon StockDEEURNov 1995
SSMX.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDApr 2011

Biography

Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and f ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/29 00:31
End of Day Share Price2020/09/10 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.